Accept Covishield, Covaxin or face mandatory quarantine, India tells EU
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Thursday
February 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
THURSDAY, FEBRUARY 02, 2023
Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

Coronavirus chronicle

TBS Report
30 June, 2021, 09:15 pm
Last modified: 30 June, 2021, 10:27 pm

Related News

  • Australia batter Usman Khawaja flies out to India after visa approved
  • How long will it take Ukraine to join EU?
  • India raises defence spending by nearly 13 per cent to ₹5.94 lakh crore
  • India Budget 2023: No income tax up to 7 lakh rupee, revised tax slabs for new regime
  • 14 dead in massive apartment fire in Jharkhand's Dhanbad

Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

Covishield and Covaxin must be notified in the European Union's digital Covid certificate, EU has been told

TBS Report
30 June, 2021, 09:15 pm
Last modified: 30 June, 2021, 10:27 pm
Accept Covishield, Covaxin or face mandatory quarantine, India tells EU

The European Union's reluctance in accepting Indian-made vaccines for its 'vaccination passport' has triggered a face-off with New Delhi.

Sources in the foreign ministry said India will begin a reciprocal policy when it comes to exemption from quarantine, report sthe NDTV.

This would mean that unless the European Union accepts Covishield and Covaxin certificates, their certificates will not be accepted in the country and people from EU will face mandatory quarantine upon arrival in India.

European Union has been told that Covishield and Covaxin must be notified in its digital Covid certificate, sources said.  

Under the new "Green Pass" scheme, people vaccinated with Covishield are unlikely to be allowed to travel to the member states of European Union.  

The EU countries accept only the vaccines approved by the European Medicines Agency, which are Pfizer, Moderna, AstraZeneca, and Janssen. But Covishield, which is the Indian version of AstraZeneca, is yet to get their clearance.

Asked about the discrepancy by news agency ANI, Ugo Astuto, the European Union ambassador to India, said, Every approval process of vaccine must be conducted on its own merit".

Yesterday, Serum Institute sources said has applied for EU's nod for Covishield through its European partner, AstraZeneca. But European Medicines Agency said they have not received a request for the approval of Covishield.

On Tuesday, foreign minister S Jaishankar took up the issue of inclusion of Covishield in the Vaccination Passport with a top EU official. "Discussed vaccine production and access. Took up 'Covishield' authorisation for travel to Europe. Will be following up," Mr Jaishankar tweeted.

So far, only those vaccinated with either of the four vaccines -- Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson's Janssen – do not face travel restrictions.

Without the approval of the EMA, nations importing Covishield will face legal issues. Indigenously made Covaxin is awaiting approval from the WHO for emergency use authorisation.

Top News

COVAXIN / Covishield / India / EU

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational image. Photo: Mohammad Minhaj Uddin/TBS
    Export earnings saw 5.89% growth in January
  • Representational image/File photo
    Stocks trading higher on narrowing trade deficit, inching up remittance inflow
  • Song of the farmers as boro begins
    Song of the farmers as boro begins

MOST VIEWED

  • Tourists ride a tour bus in Hong Kong, China October 25, 2019. REUTERS/Ammar Awad
    Hong Kong says 'hello' to woo back visitors after Covid
  • People wearing face masks following the coronavirus disease (Covid-19) outbreak are seen at Beijing Daxing International Airport in Beijing, China July 23, 2020. Photo:Reuters
    Pandemic to paradise: Chinese tourists return to Bali after three years
  • People walk outside wearing masks during the coronavirus disease (COVID-19) pandemic in the Harlem area of the Manhattan borough of New York City, New York, U.S., February 10, 2022. REUTERS/Carlo Allegri
    US to end Covid-19 emergency declarations on 11 May
  • A nurse prepares a shot for Jonathan Halter as the German embassy begins its roll out of BioNTech COVID-19 vaccines for German expatriates at a Beijing United Family hospital in Beijing, China January 5, 2023. REUTERS/Thomas Peter/File Photo
    Covid remains a public health emergency, says WHO
  • FIKE PHOTO: Medical staff moves a patient into a fever clinic at a hospital, as coronavirus disease (COVID-19) outbreaks continue in Shanghai, China, December 19, 2022. REUTERS/Aly Song
    China approves two domestically developed Covid drugs
  • People walk with their luggage at a railway station during the annual Spring Festival travel rush ahead of the Chinese Lunar New Year, as the coronavirus disease (COVID-19) outbreak continues, in Shanghai, China January 16, 2023. REUTERS/Aly Song
    Holiday trips within China surge after lifting of Covid curbs

Related News

  • Australia batter Usman Khawaja flies out to India after visa approved
  • How long will it take Ukraine to join EU?
  • India raises defence spending by nearly 13 per cent to ₹5.94 lakh crore
  • India Budget 2023: No income tax up to 7 lakh rupee, revised tax slabs for new regime
  • 14 dead in massive apartment fire in Jharkhand's Dhanbad

Features

Six Jeep Wranglers and a special XJ Jeep Cherokee set out into the depths of Lalakhal, Sylhet for an experience of a lifetime. Photo: Ahbaar Mohammad

Jeep Life Bangladesh: A club for Jeep owners to harness the power of their vehicles

3h | Wheels
While the Padma bridge in operation is changing the lives of millions in the south for the better, passenger rush to Shimulia ghat died down. Photo: Masum Billah

How are the Shimulia ghat businesses faring after Padma bridge?

5h | Panorama
After so many investments going embarrassingly wrong, as was the case with Sam Bankman-Fried, perhaps tech investors’ preference for less experience will wane. Photo: Bloomberg

Are you the next Steve Jobs? Good luck raising money in 2023

5h | Panorama
An elderly couple's lonely battle to save Dhaka's trees

An elderly couple's lonely battle to save Dhaka's trees

1d | Panorama

More Videos from TBS

Is Hathurusingha the most successful coach of Bangladesh?

Is Hathurusingha the most successful coach of Bangladesh?

18h | TBS SPORTS
Semiconductor, pharma should get more attention

Semiconductor, pharma should get more attention

20h | TBS Round Table
Dhali Al Mamun’s art depicts colonial impact

Dhali Al Mamun’s art depicts colonial impact

19h | TBS Stories
Jewel's humanitarian store

Jewel's humanitarian store

17h | TBS Stories

Most Read

1
Bapex calls candidates for job test 9 years after advert!
Bangladesh

Bapex calls candidates for job test 9 years after advert!

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Photo: Collected
Energy

8 Ctg power plants out of production

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Photo: Collected
Court

Japanese mother gets guardianship of daughters, free to leave country

6
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]